Global X Aging Population ETF · NASDAQ (us_market)
— · — · —
The fund invests more than 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that facilitate the demographic trend of longer average life spans and the aging of the global population, including but not limited to companies involved in biotechnology, medical devices, pharmaceuticals, senior living facilities and specialized health care services.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2020-02-21$24.78 RISE2020-03-23$17.20 PEAK2020-06-08$24.91 108d | -30.6% 31d | Missed | Missed | — | — | +44.8% 77d | Missed |
First quarter results point to sharpened sector divergence, separating AI-driven winners from those facing structural and geopolitical headwinds.
US growth stocks underperformed in early 2026 amid AI disruption fears and an unresolved conflict in the Middle East.
Active equity investors Carrie King and Erin Xie address key questions about healthcare stocks. Read more here.
Longevity, the length of human life, is the subject of growing scientific and commercial interest. Click here to read more.
The Trump administrationâs recent cuts at the FDA have put the agencyâs executive capacity under strain, which may lead to medicine shortages and less innovation.
The Trump administration issued several determinations under the Defense Product Act to accelerate U.S. energy supply growth and lower prices. Read more here.
ETFs like XLV stand out as aging U.S. demographics fuel rising demand for healthcare, medical devices and senior-focused care.
While AI remains the dominant theme in corporate earnings, Morningstar Research's David Sekera says investors should keep in mind that not all tech stocks are created equal. Read more here.
Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic.
We believe elevated volatility is reinforcing the case for broadening equity exposure, not stepping away from it. Read more here.
Nonresidential construction starts totaled $80.3 billion in January, a 53% year-over-year increase and one of the highest monthly totals on record.
AI applications in healthcare have emerged across four key areas: prediction, diagnosis, treatment, and system efficiency. Read more here.
Survey data underscored how the war in the Middle East has already had a material impact on economic growth around the world. Read more here.
After a 50%+ run from lows last April through highs in mid-January, the Biotech group has been trending sideways over the last few months. Read more here.
US launch of Operation Epic Fury against Iran in late February triggered the closure of the Strait of Hormuz, spiking energy prices and driving pressure on both equities and bonds.
The U.S. military campaign against the Iranian theocracy has roiled financial markets. As a result of the incursion, oil prices are surging and are up 90%+ since the beginning of the year.
Electric Power Research Instituteâs annual report shows that rapid growth in AI and cloud infrastructure is driving a sharp increase in electricity demand from data centers. Read more here.
After years of technology dominance, market leadership appears to be shifting; will it last? Click here to read more.
The fourth quarter of 2025 revealed a market increasingly defined by AIâs transformative impact across sectors.